Latest Supply Chain News

Dreadnought Resources has validated significant high-grade tungsten mineralisation at its Mangaroon and Mangaroon South projects in WA, with rock chip assays far exceeding typical global grades. Drilling at the key Nina target is slated for late 2026 or early 2027, while systematic mapping and sampling at Mangaroon South will start in September.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

Diablo Resources has secured an 80% stake in the historic Horn Silver Project in Utah, unlocking a portfolio of high-grade silver, gold, copper, and antimony targets. The acquisition complements its nearby Star Range assets and aligns with US critical minerals priorities.

Euro Manganese has signed a non-binding term sheet with US battery materials producer 6K Energy, marking a critical step towards commercialising its Chvaletice manganese project with validated product quality and supportive financing terms.

Barramundi Limited’s portfolio delivered a 2.2% gross return in July, outpacing the S&P/ASX200 hedged benchmark, driven by strong performances in healthcare and financials alongside strategic portfolio adjustments.

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.

PMET Resources posted a CAD 2.1 million net loss for Q1 2026, bolstered by strategic partnerships and a strong cash position as it pushes forward with its flagship Shaakichiuwaanaan lithium project.

InVert Graphite has completed the acquisition of RapidGraphite, gaining exclusive rights to the RapidPulse™ technology, and raised A$2.5 million to fund scale-up trials aimed at transforming battery-grade graphite production.

Jindalee Lithium's US arm has cleared the last regulatory hurdle to begin a critical Phase 1 drilling program at the McDermitt Lithium Project, aiming to upgrade resource confidence and provide key data for project feasibility.

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Baby Bunting Group delivered a 6.5% revenue rise to $556 million in FY26, alongside a 33.9% jump in pro forma net profit after tax, driven by its Store of the Future refurbishments and margin expansion.

Jindalee Lithium has taken another regulatory step by filing an amended Form S-4 with the US SEC, progressing its plan to spin out US lithium assets via US Elemental and list on NASDAQ.